Endoglycosidase S (D233Q mutant)
Endoglycosidase S (D233Q mutant) (EndoS D233Q) is a mutant endoglycosidase, which catalyzes the glycosylation of Trastuzumab (HY-P9907) -GlcNAc with the functionalized, non-natural glycans to give glycosylated monoclonal Abs (mAbs) carrying two glycans each functionalized with two reaction handles[1].
Product Specifications
Product Name Alternative
EndoS D233Q
UNSPSC
12352211
Target
Glycosidase
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Others
Smiles
[EndoglycosidaseS(D233Qmutant)]
References & Citations
[1]Thomas B Parsons, et al. Optimal Synthetic Glycosylation of a Therapeutic Antibody. Angew Chem Int Ed Engl. 2016 Feb 12;55 (7) :2361-7.
Shipping Conditions
Room temperature
Scientific Category
Enzyme
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1452923-01 0.02 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis Protein psaF (psaF)
Ask
View Details 
MBS1452923-02 0.1 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis Protein psaF (psaF)
Ask
View Details 
MBS1452923-03 0.02 mg (Yeast)
Recombinant Yersinia pseudotuberculosis Protein psaF (psaF)
Ask
View Details 
MBS1452923-04 0.1 mg (Yeast)
Recombinant Yersinia pseudotuberculosis Protein psaF (psaF)
Ask
View Details MBS1452923-05 0.02 mg (Baculovirus)
Recombinant Yersinia pseudotuberculosis Protein psaF (psaF)
Ask
View Details MBS1452923-06 0.02 mg (Mammalian-Cell)
Recombinant Yersinia pseudotuberculosis Protein psaF (psaF)
Ask
View Details